TerminatedPHASE1, PHASE2NCT00590538

Phenylbutyrate/Genistein Duotherapy in Delta F508-Heterozygotes (for Cystic Fibrosis)

Studying Cystic fibrosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Children's Hospital of Philadelphia
Principal Investigator
Ronald Rubenstein, M.D., PhD.
Children's Hospital of Philadelphia
Intervention
Sodium 4-Phenylbutyrate(drug)
Enrollment
9 enrolled
Eligibility
18 years · All sexes
Timeline
20032008

Study locations (1)

Collaborators

Cystic Fibrosis Foundation

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00590538 on ClinicalTrials.gov

Other trials for Cystic fibrosis

Additional recruiting or active studies for the same condition.

See all trials for Cystic fibrosis

← Back to all trials